Xiufeng Liu Selected Research

Xiufeng Liu Research Topics

Disease

18	Neoplasms (Cancer) 12/2023 - 02/2012
8	Hepatocellular Carcinoma (Hepatoma) 12/2023 - 01/2019
6	Melanoma (Melanoma, Malignant) 10/2021 - 02/2012
4	Infections 01/2024 - 01/2015
4	Wounds and Injuries (Trauma) 02/2018 - 11/2015
3	Inflammation (Inflammations) 01/2023 - 01/2017
3	Disease Progression 01/2023 - 01/2020
3	Breast Neoplasms (Breast Cancer) 01/2022 - 11/2017
3	Carcinoma (Carcinomatosis) 01/2019 - 04/2013
2	Thrombosis (Thrombus) 03/2024 - 03/2024
2	Body Weight (Weight, Body) 01/2023 - 01/2020
2	COVID-19 12/2022 - 10/2021
2	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 01/2020 - 01/2019
2	Experimental Arthritis 12/2018 - 01/2018
2	Hypoxia (Hypoxemia) 01/2015 - 02/2012
1	Babesiosis (Piroplasmosis) 01/2024
1	Insulin Resistance 01/2023
1	Lung Neoplasms (Lung Cancer) 01/2023
1	Dysbiosis 01/2023
1	Obesity 01/2023
1	Cholangiocarcinoma 01/2023
1	Hyperalgesia 05/2022
1	Mood Disorders (Mood Disorder) 01/2022
1	Vomiting 01/2022
1	Pica (Geophagia) 01/2022
1	Nausea 01/2022
1	Anorexia 01/2022
1	Lung Diseases (Lung Disease) 10/2021
1	Cough 10/2021
1	Asthma (Bronchial Asthma) 10/2021
1	Bacterial Infections (Bacterial Infection) 10/2021
1	Infertility (Sterility) 01/2021
1	Myocarditis (Carditis) 04/2020
1	Parkinson Disease (Parkinson's Disease) 01/2020
1	Dyskinesias (Dyskinesia) 01/2020
1	Hypertension (High Blood Pressure) 01/2019
1	Hepatitis 01/2019
1	Fibrosis (Cirrhosis) 01/2019
1	Liver Diseases (Liver Disease) 01/2019
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2019

Drug/Important Bio-Agent (IBA)

8	Proteins (Proteins, Gene)FDA Link 03/2024 - 12/2013
6	Immune Checkpoint InhibitorsIBA 12/2023 - 01/2019
4	LigandsIBA 01/2023 - 02/2012
3	Biomarkers (Surrogate Marker)IBA 03/2021 - 01/2020
3	VNP 20009 (VNP20009)IBA 01/2017 - 02/2012
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 12/2013 - 02/2012
2	Tyrosine Kinase InhibitorsIBA 12/2023 - 01/2020
2	Sorafenib (BAY 43-9006)FDA Link 01/2021 - 01/2019
2	NivolumabIBA 04/2020 - 01/2020
2	Imatinib Mesylate (Gleevec)FDA Link 01/2020 - 01/2019
2	Sunitinib (Sutent)FDA Link 01/2020 - 01/2019
2	toripalimabIBA 01/2020 - 01/2020
2	apatinibIBA 01/2019 - 01/2019
2	DC32IBA 12/2018 - 01/2018
2	artenimol (dihydroartemisinin)IBA 12/2018 - 01/2018
2	CelluloseIBA 02/2018 - 11/2015
2	Messenger RNA (mRNA)IBA 01/2018 - 06/2015
2	Silver Sulfadiazine (SSD)FDA LinkGeneric 02/2017 - 11/2015
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2017 - 06/2015
2	Urokinase Plasminogen Activator ReceptorsIBA 10/2014 - 01/2014
1	IntegrinsIBA 03/2024
1	ImmunosorbentsIBA 01/2024
1	EnzymesIBA 01/2024
1	pembrolizumabIBA 03/2023
1	tributyl phosphate (TBP)IBA 01/2023
1	Tight Junction ProteinsIBA 01/2023
1	LipidsIBA 01/2023
1	CytokinesIBA 01/2023
1	Serotonin (5 Hydroxytryptamine)IBA 01/2022
1	Neurotransmitter Agents (Neurotransmitter)IBA 01/2022
1	Cisplatin (Platino)FDA LinkGeneric 01/2022
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2022
1	KaolinIBA 01/2022
1	AcidsIBA 10/2021
1	Angiotensin-Converting Enzyme 2IBA 10/2021
1	SARS-CoV-2 spike proteinIBA 10/2021
1	FlagellinIBA 10/2021
1	atezolizumabIBA 06/2021
1	Bevacizumab (Avastin)FDA Link 06/2021
1	Estrogens (Estrogen)FDA Link 01/2021
1	ZearalenoneIBA 01/2021
1	donafenibIBA 01/2021
1	camrelizumabIBA 04/2020
1	Gemcitabine FDA Link 04/2020
1	GlucocorticoidsIBA 04/2020
1	Dasatinib (BMS 354825)FDA Link 01/2020
1	Levodopa (L Dopa)FDA LinkGeneric 01/2020
1	Tumor Biomarkers (Tumor Markers)IBA 02/2019
1	corydalmineIBA 01/2019
1	Morphine (MS Contin)FDA LinkGeneric 01/2019

Therapy/Procedure

18	Therapeutics 03/2024 - 02/2012
7	Drug Therapy (Chemotherapy) 12/2023 - 03/2014
4	Immunotherapy 12/2023 - 01/2019
1	Blood Transfusion (Blood Transfusions) 01/2024
1	Hospice Care (Care, Bereavement) 12/2022
1	Intraperitoneal Injections 05/2022
1	Chinese Traditional Medicine (Traditional Chinese Medicine) 10/2021
1	Traditional Medicine (Folk Remedies) 10/2021
1	Hepatectomy 03/2021
1	Precision Medicine 02/2019